JP2022549834A5 - - Google Patents
Info
- Publication number
- JP2022549834A5 JP2022549834A5 JP2022518780A JP2022518780A JP2022549834A5 JP 2022549834 A5 JP2022549834 A5 JP 2022549834A5 JP 2022518780 A JP2022518780 A JP 2022518780A JP 2022518780 A JP2022518780 A JP 2022518780A JP 2022549834 A5 JP2022549834 A5 JP 2022549834A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025061214A JP2025111476A (ja) | 2019-09-25 | 2025-04-02 | 高フェニルアラニン血症の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962905720P | 2019-09-25 | 2019-09-25 | |
| US62/905,720 | 2019-09-25 | ||
| PCT/US2020/052871 WO2021062264A1 (en) | 2019-09-25 | 2020-09-25 | Methods for treating hyperphenylalaninemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061214A Division JP2025111476A (ja) | 2019-09-25 | 2025-04-02 | 高フェニルアラニン血症の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022549834A JP2022549834A (ja) | 2022-11-29 |
| JP2022549834A5 true JP2022549834A5 (https=) | 2023-10-02 |
| JP7661315B2 JP7661315B2 (ja) | 2025-04-14 |
Family
ID=72827023
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518780A Active JP7661315B2 (ja) | 2019-09-25 | 2020-09-25 | 高フェニルアラニン血症の治療方法 |
| JP2025061214A Pending JP2025111476A (ja) | 2019-09-25 | 2025-04-02 | 高フェニルアラニン血症の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061214A Pending JP2025111476A (ja) | 2019-09-25 | 2025-04-02 | 高フェニルアラニン血症の治療方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20220362249A1 (https=) |
| EP (1) | EP4034122B1 (https=) |
| JP (2) | JP7661315B2 (https=) |
| KR (1) | KR20220070477A (https=) |
| CN (1) | CN114650825A (https=) |
| BR (1) | BR112022003719A2 (https=) |
| CA (1) | CA3150003A1 (https=) |
| DK (1) | DK4034122T3 (https=) |
| ES (1) | ES3041002T3 (https=) |
| FI (1) | FI4034122T3 (https=) |
| HR (1) | HRP20251268T1 (https=) |
| HU (1) | HUE073483T2 (https=) |
| IL (1) | IL291565B1 (https=) |
| JO (1) | JOP20220042A1 (https=) |
| LT (1) | LT4034122T (https=) |
| MX (1) | MX2022003585A (https=) |
| PL (1) | PL4034122T3 (https=) |
| PT (1) | PT4034122T (https=) |
| RS (1) | RS67295B1 (https=) |
| SI (1) | SI4034122T1 (https=) |
| SM (1) | SMT202500493T1 (https=) |
| WO (1) | WO2021062264A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA46973A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Polymorphes de sépiaptérine et leurs sels |
| MA46972A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Forme polymorphe de sépiaptérine |
| JP7811085B2 (ja) | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| FI3801536T3 (fi) | 2018-05-30 | 2024-08-29 | Ptc Therapeutics Mp Inc | Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi |
| EP3801534B1 (en) * | 2018-05-30 | 2026-02-18 | PTC Therapeutics MP, Inc. | Treatment of phenylketonuria with sepiapterin |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5910304A (en) | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
| CA1320905C (en) | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
| US6036949A (en) | 1998-03-05 | 2000-03-14 | Amarillo Biosciences, Inc. | Treatment of fibromyalgia with low doses of interferon |
| ES2586945T3 (es) * | 2014-03-31 | 2016-10-19 | Vasopharm Gmbh | Composiciones farmacéuticas sólidas que comprenden derivados de biopterina y usos de dichas composiciones |
| MA46973A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Polymorphes de sépiaptérine et leurs sels |
| MA46972A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Forme polymorphe de sépiaptérine |
| JP7811085B2 (ja) * | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| AU2019277372B2 (en) | 2018-05-30 | 2024-12-19 | Ptc Therapeutics Mp, Inc. | Pharmaceutically acceptable salts of sepiapterin |
-
2020
- 2020-09-24 IL IL291565A patent/IL291565B1/en unknown
- 2020-09-25 HR HRP20251268TT patent/HRP20251268T1/hr unknown
- 2020-09-25 EP EP20789788.5A patent/EP4034122B1/en active Active
- 2020-09-25 SM SM20250493T patent/SMT202500493T1/it unknown
- 2020-09-25 PL PL20789788.5T patent/PL4034122T3/pl unknown
- 2020-09-25 US US17/764,003 patent/US20220362249A1/en active Pending
- 2020-09-25 SI SI202030677T patent/SI4034122T1/sl unknown
- 2020-09-25 RS RS20250917A patent/RS67295B1/sr unknown
- 2020-09-25 JP JP2022518780A patent/JP7661315B2/ja active Active
- 2020-09-25 CN CN202080067020.4A patent/CN114650825A/zh active Pending
- 2020-09-25 PT PT207897885T patent/PT4034122T/pt unknown
- 2020-09-25 HU HUE20789788A patent/HUE073483T2/hu unknown
- 2020-09-25 MX MX2022003585A patent/MX2022003585A/es unknown
- 2020-09-25 FI FIEP20789788.5T patent/FI4034122T3/fi active
- 2020-09-25 CA CA3150003A patent/CA3150003A1/en active Pending
- 2020-09-25 LT LTEPPCT/US2020/052871T patent/LT4034122T/lt unknown
- 2020-09-25 BR BR112022003719A patent/BR112022003719A2/pt unknown
- 2020-09-25 DK DK20789788.5T patent/DK4034122T3/da active
- 2020-09-25 ES ES20789788T patent/ES3041002T3/es active Active
- 2020-09-25 WO PCT/US2020/052871 patent/WO2021062264A1/en not_active Ceased
- 2020-09-25 KR KR1020227013671A patent/KR20220070477A/ko active Pending
-
2022
- 2022-02-22 JO JOP/2022/0042A patent/JOP20220042A1/ar unknown
-
2025
- 2025-04-02 JP JP2025061214A patent/JP2025111476A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022549834A5 (https=) | ||
| US4920122A (en) | Pharmaceutical composition and method for the treatment of infantile autism | |
| US6007824A (en) | Natural composition and method for the treatment of sexual dysfunction | |
| US6335021B1 (en) | Composition for controlling mood disorders in healthy individuals | |
| JP2024069192A5 (https=) | ||
| FI4034122T3 (fi) | Menetelmiä hyperfenyylialaninemian hoitamiseksi | |
| JPH05194229A (ja) | プテリン誘導体からなる精神疾患症状の治療剤 | |
| BE1004168A3 (fr) | Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv. | |
| EP2968309A2 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| CN102805746B (zh) | 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用 | |
| EP2338495A1 (en) | Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease | |
| CA2654557A1 (en) | Combination preparations comprising bifeprunox and l-dopa | |
| JP2001518481A (ja) | 経口投与のためのセロトニン含有製剤及びその使用方法 | |
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および／または症状軽減剤 | |
| JPH03170475A (ja) | 抑うつ症治療剤 | |
| WO2021213502A1 (zh) | 包含稀有人参皂苷Rg6和F4的改善睡眠药物组合物 | |
| JPH02188523A (ja) | 睡眠時無呼吸症治療薬 | |
| JPH04342528A (ja) | アルコール代謝およびアセトアルデヒド代謝促進剤 | |
| Obel et al. | Potassium supplementation versus bendrofluazide in mildly to moderately hypertensive Kenyans | |
| JP2891738B2 (ja) | アルコール吸収抑制剤 | |
| JPWO2003022290A1 (ja) | 糖尿病性神経障害用医薬組成物 | |
| CN104645334A (zh) | N-乙酰半胱氨酸活性炭组合物及其制备方法和应用 | |
| TW200940075A (en) | Agent for alleviating adverse side effects produced in interferon/ribavirin combination therapy | |
| WO2020207344A1 (zh) | 匹莫齐特和甲氨蝶呤的药物组合及其应用 |